Status:
COMPLETED
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation
Lead Sponsor:
Allergopharma GmbH & Co. KG
Conditions:
Allergy
Rhinitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Efficacy and Safety from a high-dosed sublingual grass pollen preparation
Eligibility Criteria
Inclusion
- Allergic rhinoconjunctivitis attributable to grass pollen
- Positive SPT
- Positive EAST
- Positive provocation Test
Exclusion
- Serious chronic disease
- other perennial allergies
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00623701
Start Date
March 1 2008
End Date
October 1 2012
Last Update
November 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof. Kristian Reich, MD
Hamburg, Germany, 20354